GSK Allots $2 Billion For India Deal To Aid Expansion Plans, CEO Says
This article was originally published in PharmAsia News
Executive Summary
GlaxoSmithKline plans to spend as much as $2 billion to make a pharma deal in India to lead its expansion plans in the country